Rockefeller Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
Rockefeller Capital Management's COLL Position: Q3 2026 in Review
Rockefeller Capital Management increased its Collegium Pharmaceutical (COLL) stake by 58% in Q3 2026, buying an estimated $1.05K and bringing the position to 98 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #4552.
Rockefeller Capital Management first reported a position in COLL in Q1 2020 and has held it in 13 quarters since. The position peaked at $15K in Q3 2020. 185 funds tracked by Wall St. Rank hold COLL as of Q3 2026.
- Rockefeller Capital Management held 98 shares of Collegium Pharmaceutical worth $2.14K as of Q3 2026.
- Rockefeller Capital Management bought 36 Collegium Pharmaceutical shares in Q3 2026, an estimated $1.05K.
- Collegium Pharmaceutical made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4552 holding.
- Rockefeller Capital Management first reported a position in Collegium Pharmaceutical in Q1 2020 and has held it in 13 quarters since.
- Rockefeller Capital Management's Collegium Pharmaceutical position peaked at $15K in Q3 2020.
- 185 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.